Clinical study using positron emission tomography(PET)

Clinical study using positron emission tomography(PET) - PET imaging of Aquapolin-1,4 using TGN020

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005626

Enrollment

100

Registered

2011-05-22

Start date

2011-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor,epilepsy,multiple sclerosis, neuromyelitis,Duchenne musclar dystrophy,Alzheimer&#39

Interventions

Image analysis for the distribution of AQP1,4 between normalvolunteer and associated patients (once administration)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy adult volunteer and patients of disease associated with AQP4

Exclusion criteria

Exclusion criteria: The person that an examination for 30-minute imaging is impossible

Design outcomes

Primary

Measure	Time frame
in vivo imaging of the distribution of AQP1,4 and clinical condition elucidation of the disease group associated with AQP1,4	—

Countries

Japan

Contacts

Public ContactYuji Suzuki

University of Niigata Center for Integrated Human Brain Science

yuji-s@bri.niigata-u.ac.jp025-227-0683

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026